Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Vascular ; 30(2): 349-356, 2022 Apr.
Article in English | MEDLINE | ID: mdl-33878955

ABSTRACT

BACKGROUND: The endovascular technique of mechanochemical ablation (MOCA) has become popular in treating patients with saphenous reflux. We reported the histopathological findings in human ex-vivo incompetent great saphenous veins following treatment with saline, polidocanol, mechanical ablation and MOCA using ClariVein device. METHODS: Twenty-four vein GSV specimens were obtained via traditional surgery and treated with four methods: Group A: 0.9% normal saline (NS); Group B: 3% polidocanol; Group C: mechanical ablation + 0.9% NS; Group D: mechanical ablation + 3% polidocanol (MOCA). Hematoxylin and eosin (HE), Masson's trichrome and immunohistochemical staining were performed on each specimen and integrated optical densities were measured with vWF and a-SMA stains and statistically evaluated. vWF staining was used to assess endothelial damage and a a-SMA staining was used to assess media injury. RESULTS: HE and Masson's trichrome staining of Groups C and D revealed severe damage to the endothelium and media compared to Groups A and B. The statistical result of vWF staining showed the damage of endothelium was significantly increased by Group D compared to Groups A, B and C. The statistical result of a-SMA staining showed the damage of media was significantly increased by Groups C and D compared to Groups A and B. CONCLUSIONS: The mechanism of MOCA was caused by both endothelium damage and media tearing. The damage of endothelium was significantly increased by MOCA when compared with mechanical ablation alone.


Subject(s)
Ablation Techniques , Varicose Veins , Venous Insufficiency , Ablation Techniques/adverse effects , Humans , Polidocanol , Saphenous Vein/diagnostic imaging , Saphenous Vein/pathology , Saphenous Vein/surgery , Sclerotherapy/adverse effects , Treatment Outcome , Varicose Veins/diagnostic imaging , Varicose Veins/surgery , Venous Insufficiency/diagnostic imaging , Venous Insufficiency/surgery
2.
Ann Vasc Surg ; 74: 367-381, 2021 Jul.
Article in English | MEDLINE | ID: mdl-33556529

ABSTRACT

OBJECT: The study sought to compare the safety and effectiveness of drug-coated balloon (DCB) with bare nitinol stent in patients with complex femoropopliteal(FP) lesions in real-world practice. METHODS: Patients with symptomatic (Rutherford stage 2 to 5) femoropopliteal lesions who underwent DCB or bare nitinol stent implantation at the Department of Cardiovascular Surgery of China-Japan Friendship Hospital from June 2016 to September 2017 were included. Demographics, angiographic and procedural variables were included. Freedom from target lesion revascularization (TLR), primary patency and major adverse events were obtained from follow-up results at 3,6 and12 months. Descriptive analysis was performed on all variables. RESULTS: A total of 90 eligible patients were enrolled, which included 51 DCB subjects (mean age, 63.1 ± 13.2 years; 76.5% male) with 55 lesions and 39 nitinol stent subjects (mean age, 66.5 ± 10.5 years; 61.5% male) with 42 lesions. Significant higher primary patency was observed in the DCB group compared with the stent group (74.5% vs. 52.4%; log-rank test P = 0.018; HR 0.335, 95%CI 0.124-0.903, P = 0.031). The rates of freedom from TLR (f-TLR) were 78.2% and 59.5% (log-rank test P = 0.032) for the DCB group and the stent group, respectively, at 12 months. CD-TLR rates were 18.2% vs. 38.1% with a P-value of 0.023. Female sex (HR 6.122, 95%CI 1.880-19.934, P = 0.003), lesion length over 20 cm (HR 5.514, 95%CI 2.312-13.148, P < 0.001) and renal insufficiency (HR 2.609, 95%CI 1.087-6.260, P = 0.032) were suggested as independent risk factors of reducing primary patency. There were no significant differences in major adverse events between the 2 groups. CONCLUSION: The result above demonstrates that DCB treatment has higher primary patency and lower TLR at 12 months than nitinol stent. These data confirm the safety and effectiveness of the DCB for patients with complex femoropopliteal lesions.


Subject(s)
Angioplasty, Balloon , Peripheral Arterial Disease/therapy , Stents , Aged , Alloys , Coated Materials, Biocompatible , Female , Femoral Artery/surgery , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Nickel , Popliteal Artery/surgery , Proportional Hazards Models , Prosthesis Design , Retrospective Studies , Self Expandable Metallic Stents , Titanium , Vascular Patency
3.
J Vasc Surg Venous Lymphat Disord ; 11(1): 143-148, 2023 01.
Article in English | MEDLINE | ID: mdl-35940448

ABSTRACT

OBJECTIVE: The objective of this research was to retrospectively investigate the difference of safety and efficacy between polidocanol foam and bleomycin polidocanol foam (BPF) in the treatment of venous malformations (VMs), and provide clinical evidence for the application of BPF for VMs. METHODS: Patients with VMs treated with polidocanol foam and BPF were included between July 2018 and July 2020. The VM tissue involvements and symptoms were collected. The treatment outcomes were evaluated by the clinical improvement of symptoms and the degree of devascularization on ultrasound examination or magnetic resonance imaging. Patients were followed up for 1, 3, and 6 months after the sclerotherapy. Immediate and delayed complications were closely followed and recorded. RESULTS: A total of 51 patients were included, including 34 females and 17 males with a mean age of 26.8 years (range, 5-65 years). The most commonly involved sites were lower extremities (31/60 [51.7%]) and the most common symptom was pain (33/51 [64.7%]). Fifty-four sclerotherapies were performed with a mean of 1.06 ± 0.24 sessions (range, 1-2 sessions) per patient. The reduction percentage of lesion volume in the BPF group was significantly higher than the polidocanol foam group (79.4 ± 1.6% vs 55.7 ± 6.1%; P < .001). Patient satisfaction scores in the BPF group were significantly higher than the polidocanol foam group (7.2 ± 1.1 vs 5.7 ± 0.8; P < .001). No major complication was observed in either group. Cardiovascular and Interventional Radiological Society of Europe (CIRSE) grade 1 complications occurred in 5 of 21 patients in the BPF group and 7 of 30 patients in the polidocanol foam group, CIRSE grade 2 complications occurred in 5 of 21 patients in the BPF group and 4 of 30 patients in the polidocanol foam group; there were no significant differences between the two groups. CONCLUSIONS: BPF is a safe and effective sclerosant for VMs, showing better efficacy and similar safety as commonly used mild sclerosants. It could be a promising agent to treat VMs or other slow-flow vascular malformations.


Subject(s)
Bleomycin , Vascular Malformations , Male , Female , Humans , Adult , Polidocanol , Bleomycin/adverse effects , Retrospective Studies , Sclerosing Solutions , Sclerotherapy/adverse effects , Sclerotherapy/methods , Vascular Malformations/diagnostic imaging , Vascular Malformations/therapy , Treatment Outcome
4.
Zhongguo Zhen Jiu ; 25(4): 265-8, 2005 Apr.
Article in Zh | MEDLINE | ID: mdl-16309104

ABSTRACT

OBJECTIVE: To approach to recognition of links between the brain and meridians at the early stage of formation of TCM theory. METHODS: The relative papers in the Huangdi's Internal Classic were analyzed, compared, induced and synthesized, attaining the recognition of links between the brain and meridians. RESULTS: In the Huangdi's Internal Classic, it is indicated that the main meridians directly connected with the brain have The Foot-Yangming, The Foot-Taiyang Channels, and The Governor and The Qiao Vessels; the eye system, the vertex, Fengfu (GV 16) and the jaw are the parts of the meridians passing in and out the brain; in the brain there are some pathways of meridians. CONCLUSION: The Huangdi's Internal Classic has richer recognition of the links between the brain and meridians, to which should be pay attention in clinical diagnosis of brain diseases.


Subject(s)
Medicine, Chinese Traditional , Meridians , Acupuncture Points , Acupuncture Therapy , Brain , Head , Humans
SELECTION OF CITATIONS
SEARCH DETAIL